IsoPlexis Corporation (Nasdaq: ISO), a leader in functional single-cell proteomics, today announced it will report financial results for the third quarter 2021 before market open on Wednesday, November 10, 2021.
| BRANFORD, Conn., Oct. 26, 2021 /PRNewswire/ -- IsoPlexis Corporation (Nasdaq: ISO), a leader in functional single-cell proteomics, today announced it will report financial results for the third quarter 2021 before market open on Wednesday, November 10, 2021. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.isoplexis.com. The webcast will be archived and available for replay after the event. About IsoPlexis IsoPlexis is a life science technology company building solutions to accelerate the development of curative medicines and personalized therapeutics. Our award-winning single-cell proteomics systems reveal unique biological activity in small subsets of cells, allowing researchers to connect more directly to in vivo biology and develop more precise and personalized therapies. Our integrated systems, named top innovation or design by the Scientist Magazine, Fierce, BIG Innovation, Red Dot & multiple others, are used globally to advance the field of single-cell biology into new ‘omic possibilities, as our customers generate solutions to overcome the challenges of complex diseases and therapeutics. Our products have been adopted by researchers around the world, including the top 15 global pharmaceutical companies by revenue and by nearly half of comprehensive cancer centers in the U.S. Investor Contact Press Contact
SOURCE IsoPlexis | ||
Company Codes: NASDAQ-NMS:ISO |
View original content to download multimedia:
